3.3. The Study Population 
The study approach would be to enroll all women attending the HIV clinic aged 25–49 years who had never been screened, had not been screened within the last year (those who had screened for >1 year with normal results), or had abnormal screening results at the clinic, and to obtain their consent to participate.